当前位置: 首页 >> 检索结果
181. Screening for skin cancer: U.S. Preventive Services Task Force recommendation statement.
Update of the 2001 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for skin cancer.
183. Screening for HIV in health care settings: a guidance statement from the American College of Physicians and HIV Medicine Association.
作者: Amir Qaseem.;Vincenza Snow.;Paul Shekelle.;Robert Hopkins.;Douglas K Owens.; .
来源: Ann Intern Med. 2009年150卷2期125-31页
The American College of Physicians (ACP) developed this guidance statement to present the available evidence on screening for HIV in health care settings.
184. Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians.
作者: Amir Qaseem.;Vincenza Snow.;Thomas D Denberg.;Mary Ann Forciea.;Douglas K Owens.; .
来源: Ann Intern Med. 2008年149卷10期725-33页
The American College of Physicians developed this guideline to present the available evidence on the pharmacologic management of the acute, continuation, and maintenance phases of major depressive disorder; dysthymia; subsyndromal depression; and accompanying symptoms, such as anxiety, insomnia, or neurovegetative symptoms, by using second-generation antidepressants.
185. Primary care interventions to promote breastfeeding: U.S. Preventive Services Task Force recommendation statement.
Update of a 2003 U.S. Preventive Services Task Force (USPSTF) recommendation on counseling to promote breastfeeding.
186. Behavioral counseling to prevent sexually transmitted infections: U.S. Preventive Services Task Force recommendation statement.
New U.S. Preventive Services Task Force (USPSTF) recommendations about behavioral counseling of adolescents and adults to prevent sexually transmitted infections (STIs).
187. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement.
Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for colorectal cancer.
188. Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of Physicians.
作者: Amir Qaseem.;Vincenza Snow.;Paul Shekelle.;Robert Hopkins.;Mary Ann Forciea.;Douglas K Owens.; .
来源: Ann Intern Med. 2008年149卷6期404-15页
The American College of Physicians (ACP) developed this guideline to present the available evidence on various pharmacologic treatments to prevent fractures in men and women with low bone density or osteoporosis.
189. Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.
作者: Kenneth Lin.;Robert Lipsitz.;Therese Miller.;Supriya Janakiraman.; .
来源: Ann Intern Med. 2008年149卷3期192-9页
Prostate cancer is the most common nonskin cancer in men in the United States, and prostate cancer screening has increased in recent years. In 2002, the U.S. Preventive Services Task Force concluded that evidence was insufficient to recommend for or against screening for prostate cancer with prostate-specific antigen (PSA) testing.
190. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.
Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation statement about screening for prostate cancer.
191. Screening for asymptomatic bacteriuria in adults: U.S. Preventive Services Task Force reaffirmation recommendation statement.
Reaffirmation of the 2004 U.S. Preventive Services Task Force recommendation statement about screening for asymptomatic bacteriuria in adults.
192. Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statement.
Updated U.S. Preventive Services Task Force (USPSTF) recommendation about screening for type 2 diabetes mellitus in adults.
193. Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement.
Update of 2003 U.S. Preventive Services Task Force (USPSTF) recommendation about screening for gestational diabetes.
194. Screening for osteoporosis in men: a clinical practice guideline from the American College of Physicians.
作者: Amir Qaseem.;Vincenza Snow.;Paul Shekelle.;Robert Hopkins.;Mary Ann Forciea.;Douglas K Owens.; .
来源: Ann Intern Med. 2008年148卷9期680-4页
The American College of Physicians developed this guideline to present the available evidence on risk factors and screening tests for osteoporosis in men.
195. Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians.
作者: Amir Qaseem.;Vincenza Snow.;J Thomas Cross.;Mary Ann Forciea.;Robert Hopkins.;Paul Shekelle.;Alan Adelman.;David Mehr.;Kenneth Schellhase.;Doug Campos-Outcalt.;Pasqualina Santaguida.;Douglas K Owens.; .
来源: Ann Intern Med. 2008年148卷5期370-8页
The American College of Physicians and American Academy of Family Physicians developed this guideline to present the available evidence on current pharmacologic treatment of dementia.
196. Screening for chronic obstructive pulmonary disease using spirometry: U.S. Preventive Services Task Force recommendation statement.
New U.S. Preventive Services Task Force (USPSTF) recommendation about screening for chronic obstructive pulmonary disease (COPD) using spirometry.
197. Screening for bacterial vaginosis in pregnancy to prevent preterm delivery: U.S. Preventive Services Task Force recommendation statement.
Update of the 2001 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for bacterial vaginosis in pregnancy.
198. Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: a clinical practice guideline from the American College of Physicians.
作者: Amir Qaseem.;Vincenza Snow.;Paul Shekelle.;Donald E Casey.;J Thomas Cross.;Douglas K Owens.; .;Paul Dallas.;Nancy C Dolan.;Mary Ann Forciea.;Lakshmi Halasyamani.;Robert H Hopkins.;Paul Shekelle.
来源: Ann Intern Med. 2008年148卷2期141-6页
RECOMMENDATION 1: In patients with serious illness at the end of life, clinicians should regularly assess patients for pain, dyspnea, and depression. (Grade: strong recommendation, moderate quality of evidence.) RECOMMENDATION 2: In patients with serious illness at the end of life, clinicians should use therapies of proven effectiveness to manage pain. For patients with cancer, this includes nonsteroidal anti-inflammatory drugs, opioids, and bisphosphonates. (Grade: strong recommendation, moderate quality of evidence.) RECOMMENDATION 3: In patients with serious illness at the end of life, clinicians should use therapies of proven effectiveness to manage dyspnea, which include opioids in patients with unrelieved dyspnea and oxygen for short-term relief of hypoxemia. (Grade: strong recommendation, moderate quality of evidence.) RECOMMENDATION 4: In patients with serious illness at the end of life, clinicians should use therapies of proven effectiveness to manage depression. For patients with cancer, this includes tricyclic antidepressants, selective serotonin reuptake inhibitors, or psychosocial intervention. (Grade: strong recommendation, moderate quality of evidence.) RECOMMENDATION 5: Clinicians should ensure that advance care planning, including completion of advance directives, occurs for all patients with serious illness. (Grade: strong recommendation, low quality of evidence.).
199. Screening for carotid artery stenosis: U.S. Preventive Services Task Force recommendation statement.
Update of the 1996 U.S. Preventive Services Task Force statement about screening for asymptomatic carotid artery stenosis (CAS) in the general population.
200. Screening for high blood pressure: U.S. Preventive Services Task Force reaffirmation recommendation statement.
Reaffirmation of the 2003 U.S. Preventive Services Task Force statement about screening for high blood pressure.
|